News | Page 2

Daily news and information for physicians in a range of specialties and practice settings.
The addition of ribavirin to direct-acting antiviral treatment of HCV with cryoglobulinemia aided to achieving immunological response.
Two recent studies on surgical attrition have unveiled the factors that impact dropout rates and timing, highlighting the need for better guidance and early intervention for medical students entering surgical training.
Could valbenazine or extract of Ginkgo biloba be the next therapy to come down the pipeline for the antipsychotic-induced condition?
As the number of primary care physicians shrinks, nurse practitioners have a unique opportunity to fill gaps in care.
HCV heightens the risk for kidney disease but, the disease's treatment improves rates of survival in patients on hemodialysis.
An analysis of 40-plus trials report that the closed loop system care can be the difference in 2.5 extra hours of daily normoglycemia.
Approximately 1 in every 5 men develop a urinary stricture, with urological procedures pertaining to the treatment anticipated to skyrocket with the aging of the baby boomer generation.
The investigational therapy is first being researched for safety and dosage rates before efficacy is considered.
Findings indicate that the CD32 molecule is not preferential biomarker to identify HIV silent reservoirs, but instead identifies cells that are actively infected in spite of ART.
While its safety profile was lessened, celecoxib, in comparison with naproxen and ibuprofen, remained favorable when taken with aspirin.
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.
$loginModal$